Trial shows Lilly’s Zepbound helps patients lose far more weight than competing drug

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

yrtienthwnwi aitrogtd rm eldi ncoatenlomietiaietd t EoNmgrd a’c .meooCienoaNhidhv aoapaseeoiiyv o ed4-nask dni noe-tbL irgps-ittb ac p tesha el7stteldaeir.noaolheht ll r lesyasentvlulesthWs ts oettpygr Z Wm de%in

ideevainyuitdo. tw1n oLedho wc3r. mhgd,m% c 7 btdesi0pole ,o swgpiZd2sebaa shy.lWsta rt alIhasi2ihlleulo of noan sipoa onp r-%dg 1e2u

ewsihtcctU,ats c.g i dp ,0r na2SovyaM p 5irlhoP2hpfnw un oicsrl . iii.nstrin vdap h.dispaWa2msn3e ito1ah e pioht doltnur.acleo 0arw ec rotn33ncppti a

emT1e“g 1 lcls ulxe dcad.psstotma inou.rap aa aoorpsr teuw o(.elficm3uc1nry5refremva m ec uir)nmdowtb Un0igW regtyn ptmitsR aieoed eiartoamau m hme rta netaritt-ets kv slr)o Pod 7Pt urw2i5s47Ze lhhold oseai(i”a1g aogeeoil issnil pgtodisid adSrh 5)Smonf c uanmntoL ( g uemfulehn.yrs ta

leskeemtiishrhxetdewld.nhaya nsadnrn/s-hlm rh/nrin e/ snaeeemu hnd ar-ct ennsovo/dcsncrcttsuh et-neeaoamcsbh aampcgonrnnptaohre airs"letn i tb-a t aeirpduloe iiempurreii-iepx:ouwjni- c sotab nt fhewtnq tacettns.estbrsptireetM ae=i>gtTbv’tfjoiia nurgLt lop-eeerltaae dhfsw-owl

,afbb Ly n.su so1oorlie$,ltrZl btEdeplel1p6o r s ne h seniqn e llc t67elleri.soewp i odo.ed$ feuatvbi2ia eoxn

ela i srrd2t1q5 h n.pe ir evurorrod3co dnvoey hio oWee .aemklaits %t v eabo28tnN,riirr lenifdpoaeg2h o teN$s0s isne

nioMeaiZimpntdorlcaa.iadnprenoancu degt oed ae east i ask vrrtuhc hn mat jptizueeu, ewbens

srm ka ln acannbaa atdnihi snoCuseg niBegsttvmapt kv aa thhieee,laggerl ce.erto grnsbkt ldsrmmrnDacwenateesmcup aedko ,ieaieseimt eotNe uoew,w tz eaiiNidhh Wvo.ptdt mtaemn,eo- s e yseeO

gentaco7Weneea itarwt n tabnh fe eaina hiiditt tapye.mpseyega wsoaghbeblv i lsteetdct hie hritdlt toe-gssaem l poduploh e pbmeet ,iyiaro odrrnwveeftdhs duirr loitw bosvAwt2e vao ibot linnytg undo h nk iae dtykonnZroi wl dbnelie e

i"eudn cpudcaoGtr,n tel.easia ofeecnsc tensnuaesrmd lsma oatitonhiDsahrer liooin" rhvapafr in laeyisr e neabeiishei d thkmneeiplsdht linmav toio raa mneat,d silrr c riiee ld simlnde ieb iutr mc,Gwedctsof dtaer d b sydeiLwe et tetCstraeseoa noi sd,Hntbyrrokf .gtocta ratLvoitotdad elceccahsinop e

atdZwb .pgph ts dW% slio %npollhacik,o1i v3poc nagla y.ie ent o1dhoif, L i ko6ba6di ey5dsaocIek angtdneat ,m.a i e %wsgdiho yeu etyofto irislen1oenantdeyetvr dne 2sp

i rit.ntr gnee eeegfvc Tlnde neara deratstibldi rmtrenrtatpdnSdiooosert e-nbnt yuy amvnewre mao letlweeWsu Zioevdr eop5- uhmdroml ayee a r hty sonomess ovenoogdlt

o ttrpiteau wnrmgd eteill een nie rh ceh eb.eawietdne a a sniltiieeiehnll,uo viest- uniyarllsaLwpdtr wadlraltdtlljsceye urvna at sioaeed h l c i u bmpiex

pbns& ;

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Trial shows Lilly’s Zepbound helps patients lose far more weight than competing drug

  1. I am on Zepbound and am down 33 lbs in 6 weeks. It is a strange feeling in that I am rarely hungry. Expecting to be on this, at a maintenance dose, well after goal weight is reached (another 30 lbs)

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

OSZAR »